Grotemeyer D, Pillny M, Luther B, Müller-Mattheis V, Ernst S, Sandmann W
Klinik für Gefässchirurgie und Nierentransplantation, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf,
Chirurg. 2003 Jun;74(6):547-53. doi: 10.1007/s00104-003-0632-8.
Malignant tumor invasion in the inferior vena cava (IVC) has for a long time been the limiting factor in the resection of retroperitoneal tumors. The clinical outcome in these patients depends on vascular surgical techniques, the central role of which is played by IVC reconstruction.
Within the last 7 years, 9,085 vascular reconstructive procedures were performed in our department. Six patients suffered from retroperitoneal invasion of tumor into the IVC. After tumor resection, the involved IVC segments were replaced by polytetrafluorethylene (PTFE) grafts to restore IVC continuity. In three patients, an adjunctive arteriovenous (AV) fistula was constructed.
The graft patency after a mean follow-up of 30.2 months (range 1 to 79) was 83.3%. The only graft occlusion occurred in a patient without AV fistula. There were no perioperative deaths and no major complications demanding reoperation.
In patients with tumor involvement of the IVC, clinical outcome depends on vascular surgical coprocedure. After resection of the IVC, a PTFE graft should be interposed in combination with an AV fistula. Anticoagulation and CT scan are recommended after 3 months before ligation of the AV fistula.
恶性肿瘤侵犯下腔静脉(IVC)长期以来一直是腹膜后肿瘤切除的限制因素。这些患者的临床结局取决于血管外科技术,其中IVC重建起着核心作用。
在过去7年中,我科进行了9085例血管重建手术。6例患者腹膜后肿瘤侵犯IVC。肿瘤切除后,受累的IVC节段用聚四氟乙烯(PTFE)移植物替代以恢复IVC连续性。3例患者构建了辅助动静脉(AV)瘘。
平均随访30.2个月(范围1至79个月)后移植物通畅率为83.3%。唯一的移植物闭塞发生在未构建AV瘘的患者中。无围手术期死亡,也无需要再次手术的重大并发症。
对于IVC受肿瘤累及的患者,临床结局取决于血管外科联合手术。IVC切除后,应置入PTFE移植物并联合AV瘘。建议在结扎AV瘘前3个月进行抗凝及CT扫描。